Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2023-12-02 12:06:22）
  Nakamura Ikuo
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Case report　 Rare form of extraovarian primary peritoneal papillary serous carcinoma with
solitary cystic lesion mimicking a liver tumor; report of a case 2013/04
2. Original article　 Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration 2013/07
3. Original article　 Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis 2013/11
4. Original article　 Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling 2014/04
5. Original article　 Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma 2015/04
6. Original article　 Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma 2017/02
7. Case report　 Laparoscopic Resection of an Epithelial Cyst in an Intrapancreatic Accessory Spleen 2017/12
8. Original article　 Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma 2018/01
9. Original article　 Short- and long-term outcomes of the Frey procedure for chronic pancreatitis: a single-center experience and summary of outcomes in Japan 2018/01
10. Original article　 Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma 2018/08
11. Original article　 Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients 2020/11
12. Original article　 Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma 2021/05
13. Original article　 Sulfatase-2 regulates liver fibrosis through the TGF-β signaling pathway 2021/10
14. Original article　 Liver stiffness measured by virtual touch quantification predicts the occurrence of posthepatectomy refractory ascites in patients with hepatocellular carcinoma 2022/05
15. Original article　 Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective study 2022/08
16. Original article　 Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy 2022/08
17. Original article　 Is 6 months the optimal duration of adjuvant chemotherapy for pancreatic cancer? 2023/09
18. Original article　 Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer 2023/11
Display 5 items
Display all(18)
■ Presentation
1. Delayed arterial hemorrhage after pancreaticoduodenectomy （Poster presentation，General Lecture） 2013/05/17
2. Pure laparoscopic anatomical hepatic segmentectomy for primary hepatic tumors （Oral presentation） 2013/05/29
3. Inflammatory psedotumor mimicking combined hepatocellular carcinoma and cholangiocarcinoma: report of rare case （Poster presentation，General Lecture） 2013/05/30
4. Prediction of postoperative hepatic failure after liver resection for hepatocellular carcinoma: significance of the aspartate aminotransferase-to-platelet ratio index （Poster presentation，General Lecture） 2013/05/30
5. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma （Poster presentation，General Lecture） 2013/11/02
6. Clinicopathological study of intraductal papillary neoplasms of the bile duct (IPNB) -report of four cases- （Poster presentation，General Lecture） 2014/03/24
7. Laparoscopic anatomical hepatic resection with glissonian pedicle transection （Poster presentation，General Lecture） 2014/03/24
8. The outcome of repeat hepatectomy in patients with recurrent hepatocellular carcinoma （Poster presentation，General Lecture） 2014/03/24
9. Granulocyte-Colony stimulating factor-Producing gallbladder carcinoma （Poster presentation，General Lecture） 2014/03/26
10. An organic impediment might be one of risk factor of delayed gastric emptying after pylorus preserving pancreaticoduodenectomy （Poster presentation，General Lecture） 2014/05/02
11. Laparoscopic distal pancreatectomy preserving the spleen and splenic vessels: An operation without increased morbidity （Oral presentation，General Lecture） 2014/08/08
12. Limited anatomical liver resection in HCC patients with impaired liver function （Oral presentation，Symposium/Workshop/Panel Discussion） 2014/10/04
13. Preoperative CA19-9 is a predictive value for early recurrence after resection of pancreatic adenocarcinoma （Poster presentation，General Lecture） 2014/11/06
14. The drain management after laparoscopic distal pancreatectomy （Poster presentation，General Lecture） 2014/11/08
15. Incidence, management and risk factors of bile leakage after hepatectomy for hepatocellular carcinoma （Poster presentation，General Lecture） 2015/03/20
16. Primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis （Poster presentation，General Lecture） 2015/03/20
17. The prognostic factors for recurrence after resection of intrahepatic cholangiocarcinoma  2015/03/20
18. Predictive factors of malignant intraductal papillary mucinous neoplasm of the pancreas （Oral presentation，Symposium/Workshop/Panel Discussion） 2015/04/17
19. A verification study of the fistula risk score newly launched on pancreas club website （Poster presentation，General Lecture） 2015/05/15
20. Surgical outcomes after pancreaticoduodenectomy in elderly patients （Poster presentation，General Lecture） 2015/05/15
21. Cancer associated fibroblasts in intrahepatic cholangiocarcinoma is derived from portal fibroblasts, but not hepatic stellate cells; immunohistochemical study in human tissues （Poster presentation，General Lecture） 2015/11/16
22. Laparoscopic spleen-preserving distal pancreatectomy: Is Warshaw technique safety? （Poster presentation，General Lecture） 2016/05/20
23. A surgical case of pancreatic metastasis from lung cancer （Poster presentation，General Lecture） 2016/08/04
24. Laparoscopic distal pancreatectomy with or without splenectomy: spleen and splenic vessels preservation does not increase morbidity （Oral presentation，Symposium/Workshop/Panel Discussion） 2016/08/05
25. Laparoscopic spleen-preserving distal pancreatectomy: Is the Warshaw technique safe? （Poster presentation，General Lecture） 2016/11/04
26. Prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma （Oral presentation，General Lecture） 2017/06/08
27. Could the adjuvant chemotherapy be the standard treatment for intrahepatic cholangiocarcinoma (ICC) ? （Poster presentation，General Lecture） 2017/06/09
28. SPan-1 is a predictive factor of malignant intraductal papillary mucinous neoplasm of the pancreas （Poster presentation，General Lecture） 2017/06/09
29. The impact of sarcopenia on outcomes following resection of intrahepatic cholangiocarcinoma （Poster presentation，General Lecture） 2017/06/09
30. Usefulness of the intraoperative cholangiography with contra-enhanced ultrasound in determining the cutting line of hilar biliary tract cancer （Poster presentation，General Lecture） 2017/06/09
31. The results of preoperative portal vein embolization (PVE) for major hepatectomy -Analysis of liver volume after PVE （Poster presentation，General Lecture） 2017/06/10
32. External stent versus internal stent placed across pancreaticojejunostomy after pancreaticoduodenectomy （Poster presentation，General Lecture） 2017/06/30
33. Transection using reinforced stapler reduces pancreatic fistula after distal pancreatectomy （Poster presentation，General Lecture） 2017/06/30
34. Enhanced patterns by intraoperative contrast-enhanced ultrasonography predicts the outcomes in patients with hepatocellular carcinoma after curative liver resection （Oral presentation，General Lecture） 2017/10
35. Early occurrence of hepatocellular carcinoma in patients with hepatitis C virus treated with direct-acting antivirals （Poster presentation，General Lecture） 2017/10/31
36. Impact of the preoperative Gd-EOB-DTPA-enhanced MRI on prognosis after hepatectomy in the patients with hepatocellular carcinoma （Oral presentation，General Lecture） 2017/10/31
37. Incidence, management and risk factors of bile leakage after hepatectomy for hepatocellular carcinoma （Poster presentation，General Lecture） 2018/03/09
38. Validity of total pancreatectomy （Oral presentation，General Lecture） 2018/03/09
39. A comparison of delayed gastric emptying and nutritional status after pylorus-preserving versus stomach-preserving pancreaticoduodenectomy  2018/04/26
40. Prediction of clinically relevant pancreatic fistula in the early phase after distal pancreatectomy  2018/04/26
41. Prediction of delayed arterial hemorrhaging after pancreaticoduodenectomy （Poster presentation，General Lecture） 2018/05
42. Enhanced patterns by intraoperative contrast-enhanced ultrasonography predicts the outcome for patients with HCC after curative liver resection （Oral presentation，General Lecture） 2018/05/11
43. Evaluation of risks for posthepatectomy liver failure in patients with hepatocellular carcinoma （Oral presentation，General Lecture） 2018/05/31
44. Experience of laparoscopic liver resection of caudate lobe -The knacks from our experience- （Poster presentation，General Lecture） 2018/06/08
45. Experience regarding GS chemotherapy before pancreas cancer in our hospital （Poster presentation，General Lecture） 2018/06/08
46. Outcome of treatment for pancreaticobiliary maljunction （Oral presentation，Symposium/Workshop/Panel Discussion） 2018/06/08
47. Postoperative outcome of PD in high risk patients （Poster presentation，General Lecture） 2018/06/08
48. Short-and long-term outcomes after hepatectomy for oldest-old patients with hepatocellular carcinoma （Poster presentation，General Lecture） 2018/06/08
49. Color-coded surgery of fluorescent indocyanine green-based imaging for safe left hepatic trisectionectomy （Poster presentation，General Lecture） 2018/06/09
50. Early posthepatectomy liver failure with high gamma-GTP as predictive factor for severe postoperative complication in patients with hepatocellular carcinoma （Poster presentation，General Lecture） 2018/06/09
51. Prediction and management of delayed arterial hemorrhaging after pancreaticoduodenectomy （Oral presentation，Symposium/Workshop/Panel Discussion） 2018/06/09
52. The prognosis of patients suffering from gallbladder carcinoma with invation to extrahepatic bile duct in our department （Oral presentation，Symposium/Workshop/Panel Discussion） 2018/06/09
53. Transection using a reinforced stapler reduces the incidence of pancreatic fistula after distal pancreatectomy （Poster presentation，General Lecture） 2018/09/04
54. The significance of quantifying liver stiffness before hepatectomy for patients with hepatocellular carcinoma （Poster presentation，General Lecture） 2018/11/10
55. Prediction of pancreatic fistula after distal pancreatectomy: Is it necessary to place prophylactic drain? （Poster presentation，General Lecture） 2019/05
56. Laparoscopic repeat hepatectomy following open hepatectomy: a single-institution experience （Oral presentation，General Lecture） 2019/05/09
57. Short term outcome of laparoscopic repeat hepatectomy is the same as first resection （Poster presentation，General Lecture） 2019/05/09
58. Comparison with the predictive tools to assess the difficulty of laparoscopic liver resection: Which is the best? （Poster presentation，General Lecture） 2019/05/10
59. Extended right hemihepatectomy for a giant hepatocellular carcinoma occupying the entire right lobe accompanied by intrahepatic metastasis （Oral presentation） 2019/06/13
60. Hepatectomy using a novel cart-based indocyanine green fluorescence imaging system （Poster presentation，General Lecture） 2019/06/13
61. Predictive factors of recurrence and characterization of pathologic subtypes in curatively resected ampullary carcinoma （Poster presentation，General Lecture） 2019/06/13
62. Simulation with tumor mapping by EOB-MRI and navigation with ICG fluorescence for complete resection of multiple bilobar colorectal metastases （Oral presentation） 2019/06/13
63. The perioperative assessment of liver function in patients with hepatocellular carcinoma （Poster presentation，General Lecture） 2019/06/13
64. Conversion therapy by lenvatinib in advanced hepatocellular carcinoma （Poster presentation，General Lecture） 2019/06/14
65. Outcome of laparoscopic cholecystectomy after gallbladder drainage for acute cholecystitis （Poster presentation，General Lecture） 2019/06/14
66. Pancreaticodudenectomy complicated by congenital hemophilia A: A case report and review of literature （Oral presentation） 2019/06/14
67. How to manage the patients undergoing total pancreatectomy （Poster presentation，General Lecture） 2019/06/15
68. Validation of difficulty scoring system for laparoscopic repeat hepatectomy: a single-institution experience （Poster presentation，General Lecture） 2019/06/15
69. Delineaion of the demarcation line for left hepatic trisectionectomy using ICG fluorescence – based imaging （Web announcement，General Lecture） 2020/11
70. Laparoscopic anatomic resection guided by indocyanine green fluorescence imaging – a single institution experience - （Web announcement，General Lecture） 2020/11
71. Usefulness of complexity classification as a predictor of postoperative outcomes in patients with hepatocellular carcinoma （Web announcement，General Lecture） 2020/11
72. Our experience of laparoscopic cholecystectomy for acute cholecystitis with severe inflammation （Web announcement，Symposium/Workshop/Panel Discussion） 2021/02/23
73. Outcome of treatment for congenital biliary dilatation （Web announcement，General Lecture） 2021/02/23
74. Significance of lymph node dissection for ICC （Web announcement，Symposium/Workshop/Panel Discussion） 2021/02/23
75. Validation of complexity classification as a predictor of postoperative outcomes in patients with hepatocellular carcinoma （Web announcement，Symposium/Workshop/Panel Discussion） 2021/02/23
76. Laparoscopic anatomic resection guided by indocyanine green fluorescence imaging （Web announcement，Symposium/Workshop/Panel Discussion） 2021/02/24
77. Can Medical Imaging Projection System (MIPS) reduce mental and physical stress for surgeons performing hepatectomy? （Web announcement，General Lecture） 2021/06
78. Use of water-jet scalpel for hepatectomy---vessel and tumor-capsule friendly technique （Web announcement） 2021/06
79. Impact of the aberrant right hepatic artery on the local recurrence of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy （Web announcement） 2021/06/02
80. Strategy for intrahepatic cholangiocarcinoma with lymph node swelling （Web announcement，Symposium/Workshop/Panel Discussion） 2021/06/02
81. Indication and significance of conversion surgery after Lenvatinib in patients with advanced hepatocellular carcinoma （Web announcement，Symposium/Workshop/Panel Discussion） 2021/06/03
82. Indication for neoadjuvant therapy on outcomes classified by resectability in hepatocellular carcinoma （Web announcement，Symposium/Workshop/Panel Discussion） 2021/06/03
83. Effect of projection-mapping surgical navigation on stress relief of surgeons （Symposium/Workshop/Panel Discussion） 2021/07/07
84. Debulking hepatectomy after lenvatinib for hepatocellular carcinoma with distant metastasis （Symposium/Workshop/Panel Discussion） 2021/07/08
85. ICG fluorescence guided laparoscopic segmentectomy toward the more accurate liver dissection （Symposium/Workshop/Panel Discussion） 2021/07/09
86. Current status of real-time projection mapping-assisted surgery in gallbladder cancer （Oral presentation，Symposium/Workshop/Panel Discussion） 2022/06/10
87. The usefulness of dynamic contrast-enhanced ultrasonography for evaluation of tumor viability in patients with colorectal cancer liver metastasis after chemotherapy （Poster presentation，General Lecture） 2022/06/10
88. Are the patients with 10 or more colorectal liver metastases contraindication for hepatectomy? （Poster presentation，General Lecture） 2022/06/11
89. Feasibility of conversion therapy for initially unresectable hepatocellular carcinoma after atezolizumab plus bevacizumab （Oral presentation，Symposium/Workshop/Panel Discussion） 2022/06/11
90. Tips for laparoscopic anatomical repeat hepatectomy in our hospital （Poster presentation，General Lecture） 2022/06/11
91. Validity of new criteria “7 rule” for drain removal after pancreaticoduodenectomy （Oral presentation，Symposium/Workshop/Panel Discussion） 2022/06/11
92. Proposal of resectability in hepatocellular carcinoma for future clinical trial  2022/07/20
93. Are patients with 10 or more colorectal liver metastases contraindication for hepatectomy? （Oral presentation，General Lecture） 2023/06/30
94. Obtaining a clear surgical field in laparoscopic S8 subsectionectomy using a rigid scope （Oral presentation，Symposium/Workshop/Panel Discussion） 2023/06/30
95. The usefulness of gallbladder preservation for laparoscopic repeat liver resection （Poster presentation，General Lecture） 2023/06/30
96. Examination of conversion surgery after atezolizumab plus bevacizumab treatment in advanced hepatocellular carcinoma （Poster presentation，General Lecture） 2023/07/01
97. Feasibility of neoadjuvant chemotherapy for aged patients with resectable pancreatic ductal adenocarcinoma （Poster presentation，General Lecture） 2023/07/01
98. The Diagnostic Ability for Microvascular Invasion Using Contrast Enhanced
Ultrasopnography （Oral presentation） 2023/10/27
Display 5 items
Display all(98)
mail